| |
73
20. Blaeser-Kiel, G.
Herz und Psyche: Ein verkannter prognostischer Marker
Dt. Ärztebl.11, A-680. (1997)
21. Blazer, D. G., Kessler, R. C., McGonagle, K. A., et al.
The prevalence and distribution of major depression in a national community
sample: The National Comorbidity Survey.
Am. J. Psychiatry. 151, 979-986. (1994)
22. Bolden-Watson, C., Richelson, E.
Blockade by newly-developed antidepressant of biogenic amine uptake into rat
brain synaptosomen.
Life. Sci. 52, 1023-1029 (1993).
23. Brown, H. F., DiFrancesco, D., Noble, S. J.
How does adrenaline accelerate the heart?
Nature. 280, 235-236. (1979)
24. Clerk, G. E., Rulmy, P., Verdeau-Pailles, J.
A double blind compan'son of venlafaxine and fluoxetin in patients hospitalised
for major depression and meancholia.
Int. Clin. Psychopharmacol. 9, 139-143. (1994)
25. Cohn, C. K., Robinson, D. S., Roberts, D. L., Schwiderski, U. E., O'Brien, K.,
Ieni, J. R.
Responders to antidepressant drug treatment: a study comparing nefazodone,
imipramine, and placebo in patients with major depression.
J. Clin. Psychiatry. 57 Suppl. 2, 15-8. (1996)
26. Consensus statement.
Report and recommendations of the San Antonio conference on diabetes
neuropathy.
Diabetes. Care. 11, 592-597. (1988)
27. Coplan, J. D., Papp, L. A., Pine, D., Martinez, J., Cooper, T., Rosenblum, L. A.,
Klein, D. F., Gorman, J. M.
Clinical improvement with fluoxetine therapy und noradrenergic function in
patients with panic disorder.
Arch. Gen. Psychiatry. 54, 643-648. (1997)
28. Coryell, W. H., Endicott, J., Andreasen, N. C., Keller, M. B., et al.
Depression and panic attacks: the significance of overlap as reflected in follow-
up and family study data.
Am. J. Psychiatry.145, 293-300. (1988)
29. Cossette, S., Frasure-Smith, N., Lesperance, F.
Clinical implications of a reduction in psychological distress on cardiac
prognosis in patients participating in a psychosocial intervention program.
Psychosom. Med. 63(2), 257-266. (2001)
|  |
|
| |
|
|
